drugset / Trial / NCT01122966

The Effect of Bevacizumab on the Trabeculectomy

NCT01122966

Phase 2/3 Unknown 40 enrolled Samsung Medical Center
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The investigators plan to evaluate the additive effect of intracameral and subconjunctival injections of bevacizumab in trabeculectomies with other antimetabolites.

Timeline

Start
2010-03
Primary completion
2011-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody Other

Indications